Why is Marksans Pharma falling/rising?

As of 19-Aug, Marksans Pharma Ltd's stock price is currently at 184.45, reflecting a slight increase of 0.35 or 0.19%. The stock has shown a positive trend recently, gaining 4.01% over the last two days, although it is still trading below its moving averages across various time frames. Despite this recent uptick, the stock has underperformed significantly over the past month, with a decline of 28.15%, and a year-to-date drop of 37.74%. The company's high management efficiency, indicated by a return on equity (ROE) of 17.66%, and low debt-to-equity ratio may provide some support, but the negative results declared in June, including a 38.7% fall in profit after tax compared to previous quarters, have raised concerns about its long-term growth prospects.
Broader market context shows that while the Sensex has gained 1.76% over the past week, Marksans Pharma has experienced a decline of 1.26% in the same period. This stark contrast highlights the stock's struggle to keep pace with the broader market. Additionally, the stock's performance over the last year has been disappointing, with a return of -16.35%, significantly worse than the market's average decline of -0.91%. The falling investor participation, as evidenced by a 52.1% drop in delivery volume, further indicates a lack of confidence among investors, which could be contributing to the stock's inability to capitalize on its recent gains.